|
KAT6A–EP300
(HGNC:13013, HGNC:3373)
|
MONDO:0018908
(MONDO:0018908)
|
strong |
weak |
moderate |
strong |
weak |
|
|
ZMYM2–FGFR1
(HGNC:12989, HGNC:3688)
|
MONDO:0013296
(MONDO:0013296)
|
strong |
strong |
strong |
strong |
weak |
|
|
KAT6A–LEUTX
(HGNC:13013, HGNC:31953)
|
MONDO:0018874
(MONDO:0018874)
|
moderate |
weak |
weak |
moderate |
weak |
|
|
ZBTB16–RARA
(HGNC:12930, HGNC:9864)
|
MONDO:0012883
(MONDO:0012883)
|
strong |
moderate |
moderate |
strong |
moderate |
|
|
ZBTB16–PML
(HGNC:12930, HGNC:9113)
|
MONDO:0012883
(MONDO:0012883)
|
weak |
weak |
weak |
weak |
weak |
|
|
YY1–EWSR1
(HGNC:12856, HGNC:3508)
|
MONDO:0005065
(MONDO:0005065)
|
strong |
weak |
weak |
moderate |
weak |
|
|
YWHAE–JAZF1
(HGNC:12851, HGNC:28917)
|
MONDO:0006745
(MONDO:0006745)
|
moderate |
moderate |
moderate |
moderate |
weak |
|
|
YWHAE–BCOR
(HGNC:12851, HGNC:20893)
|
clear cell sarcoma of kidney
(MONDO_0005006)
|
weak |
weak |
weak |
weak |
weak |
|
|
YWHAE–NUTM2B
(HGNC:12851, HGNC:23445)
|
endometrioid stromal sarcoma
(MONDO_0006745)
|
strong |
moderate |
moderate |
strong |
weak |
|
|
WT1–EWSR1
(HGNC:12796, HGNC:3508)
|
MONDO:0019373
(MONDO:0019373)
|
strong |
moderate |
moderate |
strong |
weak |
|
|
NSD3–NUP98
(HGNC:12767, HGNC:8068)
|
MONDO:0018874
(MONDO:0018874)
|
strong |
moderate |
strong |
strong |
weak |
|
|
NSD3–NUTM1
(HGNC:12767, HGNC:29919)
|
lung neoplasm
(MONDO_0021117)
|
moderate |
moderate |
moderate |
strong |
weak |
|
|
VCL–ALK
(HGNC:12665, HGNC:427)
|
kidney medullary carcinoma
(MONDO_0006260)
|
strong |
strong |
moderate |
strong |
weak |
|
|
NSD2–IGH
(HGNC:12766, HGNC:5477)
|
monoclonal gammopathy of uncertain significance
(MONDO_0004225)
|
strong |
moderate |
strong |
strong |
moderate |
|
|
VAV1–MYO1F
(HGNC:12657, HGNC:7600)
|
MONDO:0004992
(MONDO:0004992)
|
strong |
strong |
moderate |
moderate |
weak |
|
|
USP8–PDGFRA
(HGNC:12631, HGNC:8803)
|
MONDO:0015798
(MONDO:0015798)
|
strong |
moderate |
weak |
strong |
weak |
|
|
USP6–MYH9
(HGNC:12629, HGNC:7579)
|
MONDO:0004187
(MONDO:0004187)
|
strong |
weak |
moderate |
strong |
weak |
|
|
USP2–KMT2A
(HGNC:12618, HGNC:7132)
|
MONDO:0004996
(MONDO:0004996)
|
moderate |
moderate |
moderate |
strong |
weak |
|
|
USP6–COL1A1
(HGNC:12629, HGNC:2197)
|
MONDO:0018815
(MONDO:0018815)
|
strong |
weak |
moderate |
strong |
weak |
|
|
UBE2L3–KRAS
(HGNC:12488, HGNC:6407)
|
prostate cancer
(MONDO_0008315)
|
moderate |
weak |
weak |
moderate |
weak |
|